Payer mix improved by 135 basis points from the second quarter of 2025 and by 120 basis points from the first quarter of 2026. “There has been absolutely no sign of a change to date at Pediatrix,” Ordan said. Pediatrix generated $126 million in operating cash flow during the second quarter, compared with $138 million in the prior-year quarter. Capital Allocation and Growth PlansDuring the quarter, Pediatrix repurchased just under 2 million shares. About Pediatrix Medical Group (NYSE:MD)Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care.